Development of a RFWD2 conditional knock-out mouse line

Ended Purchase Order Awarded

Contract number
75F40120P00355
Awardee
Awarding agency
Obligated
$28,933

Award facts

Contract value 100% obligated
$28,933.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
112990 All Other Animal Production
PSC
8820 Live Animals, Not Raised For Food
Set-aside
No set-aside
Competition
Competed under SAP · 2 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Silver Spring, MD 20993, USA

Award details come from SAM.gov/FPDS.

About this award

Genoway has been awarded a firm fixed price purchase order valued at twenty-eight thousand nine hundred thirty-three dollars by the Department of Health and Human Services Food and Drug Administration to develop a RFWD2 conditional knock-out mouse line. The period of performance is scheduled to conclude on July 12, 2021. No set-aside designation was utilized for this procurement. Genoway is a for-profit biotechnology firm that specializes in developing genetically modified mouse, rat, and cell line models to support fundamental, preclinical, and clinical research. This contract supports the FDA's regulatory science and product evaluation activities through the generation of a targeted mouse model.

Quick answers

Who was awarded contract 75F40120P00355?

75F40120P00355 was awarded to Genoway by Food and Drug Administration (Department of Health and Human Services) on July 9, 2020.

How much is contract 75F40120P00355 worth?

The government has obligated $28,933 on 75F40120P00355.

Was contract 75F40120P00355 competed?

The extent of competition for 75F40120P00355 was competed under sap. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award